company background image
KLBF logo

Kalbe Farma IDX:KLBF Stock Report

Last Price

Rp1.57k

Market Cap

Rp72.2t

7D

0.3%

1Y

-23.4%

Updated

21 Jun, 2024

Data

Company Financials +

KLBF Stock Overview

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

KLBF fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends4/6

PT Kalbe Farma Tbk. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kalbe Farma
Historical stock prices
Current Share PriceRp1,570.00
52 Week HighRp2,090.00
52 Week LowRp1,375.00
Beta0.15
11 Month Change0.64%
3 Month Change5.72%
1 Year Change-23.41%
33 Year Change15.87%
5 Year Change7.53%
Change since IPO13,461.41%

Recent News & Updates

Recent updates

Shareholder Returns

KLBFID PharmaceuticalsID Market
7D0.3%0.1%1.7%
1Y-23.4%-23.1%1.1%

Return vs Industry: KLBF matched the ID Pharmaceuticals industry which returned -22.5% over the past year.

Return vs Market: KLBF underperformed the ID Market which returned 0.5% over the past year.

Price Volatility

Is KLBF's price volatile compared to industry and market?
KLBF volatility
KLBF Average Weekly Movement3.8%
Pharmaceuticals Industry Average Movement7.3%
Market Average Movement5.8%
10% most volatile stocks in ID Market12.9%
10% least volatile stocks in ID Market2.6%

Stable Share Price: KLBF has not had significant price volatility in the past 3 months.

Volatility Over Time: KLBF's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196613,062. Vidjongtiuswww.kalbe.co.id

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products.

PT Kalbe Farma Tbk. Fundamentals Summary

How do Kalbe Farma's earnings and revenue compare to its market cap?
KLBF fundamental statistics
Market capRp72.16t
Earnings (TTM)Rp2.87t
Revenue (TTM)Rp30.94t

25.3x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KLBF income statement (TTM)
RevenueRp30.94t
Cost of RevenueRp19.26t
Gross ProfitRp11.68t
Other ExpensesRp8.81t
EarningsRp2.87t

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)62.02
Gross Margin37.76%
Net Profit Margin9.27%
Debt/Equity Ratio2.7%

How did KLBF perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

50%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.